Search Orphan Drug Designations and Approvals
-
| Generic Name: | humanized anti-adrenocorticotropic hormone immunoglobulin gamma subclass 1 monoclonal antibody (anti-ACTH IgG1 mAb) |
|---|---|
| Date Designated: | 05/12/2025 |
| Orphan Designation: | treatment of congenital adrenal hyperplasia (CAH) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
H. Lundbeck A/S c/o Lundbeck Pharmaceuticals LLC; Six Parkway North; Suite 400 Deerfield, Illinois 60015 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







